Main Street 1; Wall Street 0
Results 1 - 10 of 431 : 1 2 3 4 5 6 7 8 9 Next
Has Momenta Pharmaceuticals Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
Buffett and Woodford Agree on This One!
Top U.S. and U.K. investors share a passion for a French pharma giant.
Drug Fails: At Least It's Approved Already
Pfizer's Torisel fails to best Nexavar in a head-to-head trial.
Pharma companies tackle a giant unmet need.
This Cancer Drug Works, but Indication Drama Remains
Roche and ImmunoGen need first-line data.
Does Novartis Pass Buffett's Test?
Here's one of Buffett's favorite metrics for evaluating companies.
Advisory Panel Pans Drug, Investors Shrug?
It's all about ponatinib for ARIAD.
An FDA Advisory Panel Doubleheader
Glaxo's Votrient, and Taltorvic from Merck and Ariad, head in front of the firing squad.
Will Novartis Help You Retire Rich?
Stocks that give retirees what they want are incredibly valuable.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK